Jaguar Health (JAGX) Tops Q2 EPS by 3647c

Jaguar Health (NASDAQ: JAGX) reported Q2 EPS of ($15.68), $36.47 better than the analyst estimate of ($52.15). Revenue for the quarter came in at $1.23 million versus the consensus estimate of $4.24 million.

For earnings history and earnings-related data on Jaguar Health (JAGX) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Science Applications (SAIC) PT Raised to $154 at Stifel
• Goldman Sachs on Kingsoft Cloud (KC): 'AI cloud to drive revenue expansion with attractive investment payback'